{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:11:14Z","timestamp":1770037874615,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970270"],"award-info":[{"award-number":["81970270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["18ZXRHSY00180"],"award-info":[{"award-number":["18ZXRHSY00180"]}],"id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Electrocardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jelectrocard.2020.04.024","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:47:15Z","timestamp":1588535235000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy"],"prefix":"10.1016","volume":"60","author":[{"given":"Ziliang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayue","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0010","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0015","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2017.72.4211","article-title":"Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors","volume":"35","author":"Salz","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ejh.13234","article-title":"Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-pro BNP and cardiovascular score for risk stratification","volume":"102","author":"Ferraro","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0025","first-page":"4933","article-title":"Electrocardiography changes during adjuvant breast cancer therapy: incidence and risk factors","volume":"33","author":"Elme","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0030","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/echo.13704","article-title":"Early anthracycline-induced cardiotoxicity monitored by echocardiographic doppler parameters combined with serum hs-cTnT","volume":"34","author":"Zhang","year":"2017","journal-title":"Echocardiography"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12032-017-1075-2","article-title":"Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the onco-echo study","volume":"35","author":"Mizia-Stec","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ccep.2019.02.007","article-title":"The value of baseline and arrhythmic ECG in the interpretation of arrhythmic mechanisms","volume":"11","author":"Chen","year":"2019","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1573403X10666140514103612","article-title":"The measurement of the QT interval","volume":"10","author":"Postema","year":"2014","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCEP.107.763284","article-title":"Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis","volume":"1","author":"Das","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/anec.12309","article-title":"Evaluation of index of cardio-electrophysiological balance (iCEB) as a new biomarker for the identification of patients at increased arrhythmic risk","volume":"21","author":"Robyns","year":"2016","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2015.03.175","article-title":"Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis","volume":"189","author":"Nagao","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0065","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0070","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11912-018-0691-0","article-title":"Electrophysiologic toxicity of chemoradiation","volume":"20","author":"Armanious","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biopha.2004.12.003","article-title":"Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients","volume":"59","author":"Galetta","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.1999.00480.x","article-title":"QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin\u2019s lymphoma","volume":"245","author":"Nousiainen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2018.04.009","article-title":"Anticancer drug-induced cardiac rhythm disorders: current knowledge and basic underlying mechanisms","volume":"189","author":"Alexandre","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jelectrocard.2019.02.003","article-title":"Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy","volume":"54","author":"Dural","year":"2019","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000431030","article-title":"Radiotherapy induces development of fragmented QRS in patients with breast cancer","volume":"10","author":"Adar","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jelectrocard.2020.04.024_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000500439","article-title":"A novel predictor of chemotherapeutic cardiotoxicity in patients with non-Hodgkin lymphoma","volume":"42","author":"Gurdogan","year":"2019","journal-title":"Oncol Res Treat"}],"container-title":["Journal of Electrocardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073620301370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022073620301370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:50:51Z","timestamp":1762199451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022073620301370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":21,"alternative-id":["S0022073620301370"],"URL":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2020.04.024","relation":{},"ISSN":["0022-0736"],"issn-type":[{"value":"0022-0736","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Electrocardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jelectrocard.2020.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}